Koki Mise
Okayama University
87 Papers
138 Citations
Koki Mise is an academic researcher from Okayama University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 17, co-authored 75 publications. Previous affiliations of Koki Mise include University of Texas MD Anderson Cancer Center & University of Texas Health Science Center at Houston.
Chat about Author
Papers
Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease
Koichi Kikuchi,Daisuke Saigusa,Yoshitomi Kanemitsu,Yotaro Matsumoto,Paxton Thanai,Naoto Suzuki,Koki Mise,Hiroaki Yamaguchi,Tomohiro Nakamura,Kei Asaji,Chikahisa Mukawa,Hiroki Tsukamoto,Toshihiro Sato,Yoshitsugu Oikawa,Tomoyuki Iwasaki,Yuji Oe,Tomoya Tsukimi,Noriko N. Fukuda,Hsin Jung Ho,Fumika Nanto-Hara,Jiro Ogura,Ritsumi Saito,Shizuko Nagao,Yusuke Ohsaki,Satoshi Shimada,Takehiro Suzuki,Takafumi Toyohara,Eikan Mishima,Hisato Shima,Yasutoshi Akiyama,Yukako Akiyama,Mariko Ichijo,Tetsuro Matsuhashi,Akihiro Matsuo,Yoshiaki Ogata,Ching Chin Yang,Chitose Suzuki,Matthew C. Breeggemann,Jurgen Heymann,Miho Shimizu,Susumu Ogawa,Nobuyuki Takahashi,Takashi Suzuki,Yuji Owada,Shigeo Kure,Nariyasu Mano,Tomoyoshi Soga,Takashi Wada,Jeffrey B. Kopp,Shinji Fukuda,Atsushi Hozawa,Masayuki Yamamoto,Sadayoshi Ito,Jun Wada,Yoshihisa Tomioka,Takaaki Abe +55 more
TL;DR: It is shown that phenol sulfate, a gut microbiota-derived metabolite, is increased in diabetic kidney disease and contributes to the pathology by promoting kidney injury, suggesting phenyl sulfate could be used a marker and therapeutic target for the treatment of diabetic kidneys disease.
Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score–Matched Analysis of a Nationwide, Biopsy-Based Cohort Study
Masayuki Yamanouchi,Kengo Furuichi,Junichi Hoshino,Tadashi Toyama,Akinori Hara,Miho Shimizu,Keiichi Kinowaki,Takeshi Fujii,Kenichi Ohashi,Yukio Yuzawa,Hiroshi Kitamura,Yoshiki Suzuki,Hiroshi Sato,Noriko Uesugi,Satoshi Hisano,Yoshihiko Ueda,Shinichi Nishi,Hitoshi Yokoyama,Tomoya Nishino,Ken-ichi Samejima,Kentaro Kohagura,Yugo Shibagaki,Koki Mise,Hirofumi Makino,Seiichi Matsuo,Yoshifumi Ubara,Takashi Wada +26 more
TL;DR: Patients with nonproteinuric diabetic kidney disease had better-controlled blood pressure and fewer typical morphological changes and were at lower risk of CKD progression and all-cause mortality.
98
Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy
Koki Mise,Junichi Hoshino,Yoshifumi Ubara,Keiichi Sumida,Rikako Hiramatsu,Eiko Hasegawa,Masayuki Yamanouchi,Noriko Hayami,Tatsuya Suwabe,Naoki Sawa,Takeshi Fujii,Kenichi Ohashi,Shigeko Hara,Kenmei Takaichi +13 more
TL;DR: The progression of glomerular, tubulointerstitial and vascular lesions was associated with higher HRs for renal death, suggesting the clinical utility of Tervaert's pathological classification.
84
Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study
Keiichi Sumida,Y. Ubara,J. Hoshino,Koki Mise,Noriko Hayami,T. Suwabe,Masahiro Kawada,Aya Imafuku,Rikako Hiramatsu,E. Hasegawa,M. Yamanouchi,Naoki Sawa,K. Takaichi +12 more
TL;DR: Once-weekly teriparatide treatment was significantly associated with the increase in lumbar spine bone mineral density at 48 weeks among hemodialysis patients with hypoparathyroidism and low bone mass; however, discontinuation of treatment because of adverse events was frequently observed.
61
Quality of life of patients with ADPKD — Toranomon PKD QOL study: cross-sectional study
Tatsuya Suwabe,Yoshifumi Ubara,Koki Mise,Masahiro Kawada,Satoshi Hamanoue,Keiichi Sumida,Noriko Hayami,Junichi Hoshino,Rikako Hiramatsu,Masayuki Yamanouchi,Eiko Hasegawa,Naoki Sawa,Kenmei Takaichi +12 more
TL;DR: Several factors influence QOL, so improving symptoms unrelated to TLKV as well as reducing abdominal distention can improve the quality of life of ADPKD patients.